Clinical Trial Update: Experience of Mutaflor Suspension Use in Preterm Infants for Immunity Improvement

View source ↗

Summary

Completed clinical trial evaluating Mutaflor Suspension (Escherichia coli Nissle 1917) in preterm infants to improve immunity, with results posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neonatal Infection

Drugs mentioned

• Mutaflor Suspension (Escherichia coli Nissle 1917)

Snippet

Sponsor: Odessa National Medical University | Conditions: Neonatal Infection | Status: COMPLETED | Results posted: 2015-09-10